While rarely altered in human cancers in general (<0.5% of all cases), the incidence of CSMD3 disruption in UC (~14% of cases) is among the highest across cancer subtypes, along with ovarian, breast, gastric and colon carcinomas [17,38]. Here, CSMD3 is linked to cancer.